ADVERTISEMENT
oligomannate alzheimer's disease neurodegeneration microbiome seaweed drug approval china
China Approves Alzheimer’s Treatment that Targets the Microbiome
Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.
China Approves Alzheimer’s Treatment that Targets the Microbiome
China Approves Alzheimer’s Treatment that Targets the Microbiome

Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.

Oligomannate, derived from a compound in seaweed, suppresses neural inflammation caused by gut bacteria in mice.

neurodegeneration, disease & medicine, microbiology

Commensal Bacterium Reduces ALS Symptoms in Mice
Jef Akst | Jul 24, 2019 | 2 min read
Boosting the levels of Akkermansia muciniphila in mouse guts slowed the progression of an ALS-like disease, while two other microbiome members were associated with more severe symptoms.
ADVERTISEMENT